New Model Development of Pharmaceutical Care for Epilepsy Patients

Abstract

Background: Most of the drug related problems encountered in epilepsy clinics are often medication adherence which may affect seizure control.Objective: To study the effect of seizure control and medication adherence after receiving new development of pharmaceutical care for epilepsy patients at Neurological Institute of ThailandMethod: Collected data from 120 epilepsy patients who received services at the outpatients department between May 2019 and March 2020, Patients with epilepsy who had seizure frequency greater than or equal to 1 time in the past 1 month, patients who could use various research programs on smart phones and never received pharmaceutical care were selected by simple random sampling and randomly assigned to either the study group (epilepsy patients receiving the new epilepsy pharmaceutical care) or control group, each group comprised 60 patients. Seizure control and medication adherence data were collected by interviews and self-administered forms before and after received new pharmaceutical care.Result: After receiving the new epileptic pharmaceutical care, it was found that there was increase in mean scores of medication adherence and statistically significant decrease in seizure frequency (p<0.05). There was a negative correlation between increased medication adherence with reduced seizure frequency.Conclusion: New epilepsy pharmaceutical care would be helpful in making patients realize the importance of taking medicines. The more medication adherence, as a result epileptic patients can control their seizures better.